论文部分内容阅读
目的探讨放置曼月乐(左炔诺孕酮宫内缓释系统,LNG-IUS)治疗子宫腺肌病的临床疗效。方法回顾性分析56例子宫腺肌病患者放置曼月乐的临床资料,比较放置曼月乐对月经量变化、痛经视觉模拟评分法(VAS)评分、子宫体积、内膜厚度及血红蛋白变化和不良反应的影响。结果放置曼月乐3个月后,子宫腺肌病患者月经量显著减少;痛经VAS评分显著降低;血红蛋白水平显著上升;子宫内膜厚度显著变薄;子宫体积在放置12个月后显著减少,差异均具有统计学意义(P<0.05或P<0.01)。结论放置曼月乐治疗子宫腺肌病可以有效缓解患者痛经、减少月经量及改善贫血,是一种安全有效、值得推广的治疗方法。
Objective To investigate the clinical efficacy of levonorgestrel-releasing intrauterine release system (LNG-IUS) in the treatment of adenomyosis. Methods The clinical data of Mirena placed in 56 cases of adenomyosis were retrospectively analyzed. The changes of menstrual flow, VAS score, uterine volume, intima thickness, hemoglobin change and malformation The impact of the reaction. Results After 3 months of Mirena, the amount of menstruation in patients with adenomyosis was significantly reduced; the VAS score of dysmenorrhea was significantly decreased; the level of hemoglobin was significantly increased; the thickness of endometrium was significantly thinned; the uterine volume was significantly reduced after 12 months’ The differences were statistically significant (P <0.05 or P <0.01). Conclusion The application of Mirena for adenomyosis can effectively relieve dysmenorrhea, reduce menstrual flow and improve anemia. It is a safe and effective treatment that is worth popularizing.